newsfilter
← Latest News
GlobeNewswire·

Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results

REYKJAVIK, Iceland, March 04, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO) (the "Company"), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients